Summary Increasing demand of electricity and severer concerns to environment call for green energy sources as well as efficient energy conversion systems. SCO2 power cycles integrated with concentrating solar power (CSP) are capable of enhancing the competitiveness of thermal solar electricity. This article makes a comprehensive review of supercritical CO2 power cycles integrated with CSP. A detailed comparison of four typical CSP technologies is conducted, and the cost challenge of currently CSP technologies is pointed out. The thermophysical properties of sCO2 and the corresponding two real gas effects are analyzed elaborately to express the features of sCO2 power cycles. An extensive review of sCO2 layouts relevant for CSP including 12 single layouts and 1 combined layout is implemented logically. Strengths and weaknesses of sCO2 power cycles over traditional steam‐Rankine cycle generally adopted in current CSP plants are concluded, followed by metal material degration summary in CSP relevant temperature sCO2 environment, which shows that the nickel‐based alloy is a proper structural material candidate for sCO2‐CSP integration. Thermodynamic analyses of sCO2 power cycles when integrated with CSP are divided into three level of which design‐point analysis and off‐design modeling are conducted and compared, more researches into the off‐design point analysis, dynamic modeling, especially the transient behavior are suggested. Economic analysis of the integrated system is concluded and presents a considerable levelized cost of electricity reduction of 15.6% to 67.7% compared to that of state of art CSP. Taking the thermodynamic and economic analysis into consideration, target designs of sCO2 power cycles for CSP are summarized in three aspects. Finally, current theoretical and experimental researches of sCO2 power cycles integrated with CSP for market penetration are introduced. The strengths, weaknesses, and potential solutions to the gaps of three potential pathways (molten salt pathway, particle pathway, and gas phase pathway) to realize the integration of sCO2 power cycles in the next CSP generation plants up to 700°C are reviewed. In general, the integration of sCO2 power cycles with CSP technologies exhibits promising expectations for facilitating the competitiveness of thermal solar electricity.
Moving packed bed particle/supercritical carbon dioxide (SCO 2 ) heat exchanger (MPBE) is a critical equipment to integrate particle thermal energy storage technology with SCO 2 power cycle block in the next-generation concentrated solar power plants. A predictive heat transfer model for designing and evaluation of shell and plate particle/SCO 2 moving packed bed heat
PurposeThe current study aimed to investigate whether red blood cell distribution width (RDW) can predict the prognosis of patients with breast cancer (BC).MethodsWe searched four databases, including PubMed, Embase, Cochrane Library databases, and CNKI, from inception to Jun 13, 2022. The primary outcome was overall survival (OS), and the secondary outcome was disease-free survival (DFS). A subgroup analysis was conducted based on different treatments. This meta-analysis was performed with RevMan 5.3 (The Cochrane Collaboration, London, United Kingdom).ResultsA total of seven studies including 4,884 BC patients were identified. The high RDW group had a larger tumor size (OR = 2.12, 95% CI = 1.67 to 2.68, P < 0.01), higher proportions of advanced stage tumors (OR = 1.77, 95% CI = 1.38 to 2.27, P < 0.01), more lymph node metastases (OR = 2.00, 95% CI = 1.58 to 2.51, P < 0.01) and lower HER-2 expression (OR = 0.76, 95% CI = 0.61 to 0.95, P = 0.02). For prognosis, after pooling all the data, we found that the high RDW group was associated with worse OS (HR = 2.12, 95% CI = 1.47 to 3.08, P < 0.01) and DFS (HR = 1.77, 95% CI = 1.32 to 2.37, P < 0.01). The subgroup analysis found that RDW had prognostic significance but only for surgery-only patients (HR = 2.41, 95% CI = 1.67 to 3.49, P < 0.01).ConclusionHigh RDW was associated with worse OS and DFS. Therefore, RDW was a simple predictive factor for the prognosis of BC patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.